Predict your next investment

RA Capital Management company logo
Advisory
FINANCE | Asset/Financial Management
racap.com

See what CB Insights has to offer

Investments

277

Funds

6

Service Providers

1

About RA Capital Management

RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices, and diagnostics. The firm provides seed funding to startups and leads private, IPO, and follow-on financings for its portfolio companies, thereby driving value creation from idea inception through commercialization.

RA Capital Management Headquarter Location

200 Berkeley Street 18th Floor

Boston, Massachusetts, 02116,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing RA Capital Management

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find RA Capital Management in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

RA Capital Management Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

RA Capital Management Rank

Research containing RA Capital Management

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned RA Capital Management in 3 CB Insights research briefs, most recently on Aug 5, 2021.

Latest RA Capital Management News

Ra Capital Management raises passive stake in Wave Life Sciences

Jun 22, 2022

Wave Life Sciences (NASDAQ: WVE ) has disclosed a share purchase by 10% owner Ra Capital Management. Ra Capital Management bought over 9.48M shares of the company's ordinary shares at $2.15 in a transaction dated June 16, 2022. It now becomes the beneficial owner of 17,202,009 shares of the issuer's ordinary shares which constitute ~19.99% of the class outstanding. The fund also holds pre-funded warrants through which it has a right to acquire 7,093,656 ordinary shares. The pre-funded warrants contain a provision which precludes exercise of the warrants to the extent that, following exercise, the fund, together with its affiliates and other attribution parties, would own more that 19.99% of the ordinary shares outstanding. The additional securities were acquired for an aggregate of $35.63M. The purchases were for cash and were funded by the working capital of the fund. WVE shares up over 8% pre-market To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

RA Capital Management Investments

277 Investments

RA Capital Management has made 277 investments. Their latest investment was in Cerebral Therapeutics as part of their Series C on June 6, 2022.

CBI Logo

RA Capital Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/28/2022

Series C

Cerebral Therapeutics

$40M

No

3

6/8/2022

Series B

Mineralys Therapeutics

$118M

Yes

6

4/19/2022

Series B

Sionna Therapeutics

$111M

Yes

4

4/14/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

4/13/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/28/2022

6/8/2022

4/19/2022

4/14/2022

4/13/2022

Round

Series C

Series B

Series B

Series B

Series A

Company

Cerebral Therapeutics

Mineralys Therapeutics

Sionna Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$40M

$118M

$111M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

6

4

10

10

RA Capital Management Fund History

6 Fund Histories

RA Capital Management has 6 funds, including RA Capital Nexus Fund III.

Closing Date

Fund

Fund Type

Status

Amount

Sources

10/6/2021

RA Capital Nexus Fund III

$880M

1

10/21/2020

RA Capital Nexus Fund II

$99M

10

7/15/2019

RA Capital Nexus Fund

Subscribe to see more

Subscribe to see more

$99M

10

7/12/2019

RA Capital Nexus International Fund

$99M

10

RA Capital Healthcare Fund LP

Subscribe to see more

Subscribe to see more

10

Closing Date

10/6/2021

10/21/2020

7/15/2019

7/12/2019

Fund

RA Capital Nexus Fund III

RA Capital Nexus Fund II

RA Capital Nexus Fund

RA Capital Nexus International Fund

RA Capital Healthcare Fund LP

Fund Type

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Amount

$880M

$99M

$99M

$99M

Sources

1

10

10

10

10

RA Capital Management Service Providers

1 Service Provider

RA Capital Management has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

Partnership data by VentureSource

RA Capital Management Team

9 Team Members

RA Capital Management has 9 team members, including current Founder, Managing Partner, Peter Kolchinsky.

Name

Work History

Title

Status

Peter Kolchinsky

Founder, Managing Partner

Current

Michael Saulnier

Baupost Group, Centerbridge Partners, Citigroup, Ernst & Young, and Morgan Stanley

Chief Financial Officer

Current

Chris Caliri

Bain Capital, and SunGard

Chief Information Officer

Current

Klio DiCenzo

Chief People Officer

Current

Eric Rose

Chief Compliance Officer

Current

Name

Peter Kolchinsky

Michael Saulnier

Chris Caliri

Klio DiCenzo

Eric Rose

Work History

Baupost Group, Centerbridge Partners, Citigroup, Ernst & Young, and Morgan Stanley

Bain Capital, and SunGard

Title

Founder, Managing Partner

Chief Financial Officer

Chief Information Officer

Chief People Officer

Chief Compliance Officer

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.